Adult T-cell leukemia presenting with episcleritis and secondary glaucoma.
Oono
Shinichirou
S
Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Kurimoto
Takuji
T
Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. kurimoto@hyo-med.ac.jp.|Department of Ophthalmology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan. kurimoto@hyo-med.ac.jp.
Oku
Hidehiro
H
Department of Ophthalmology, Osaka Medical College, Takatsuki, Osaka, Japan.
Mimura
Osamu
O
Department of Ophthalmology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use; D003231:Conjunctivitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007429:Intraocular Pressure; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D015423:Scleritis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014065:Tonometry, Ocular; D014750:Vincristine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D001623:Betamethasone; D011241:Prednisone